In contrast, the United Kingdom’s National Institute for Health Research (NIHR), with its Clinical Research Network infrastructure, has engendered global envy by enabling rapid research production and ...

CAMBRIDGE, Mass. & ROCKVILLE, Md., April 28, 2025--Clasp Therapeutics doses first patient in the GUARDIAN-101 Phase 1 trial with a first-in-class T-Cell engager designed to target cancer cells ...

MSACL Conference 2023--Waters Corporation (NYSE:WAT) today unveiled its next generationXevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical ...